Stocks and Investing
Stocks and Investing
Wed, March 13, 2013
[ 08:32 AM ] - WealthMakers
[ 08:31 AM ] - WOPRAI
[ 08:30 AM ] - WOPRAI
[ 08:29 AM ] - WOPRAI
[ 08:27 AM ] - WOPRAI
[ 08:26 AM ] - WOPRAI
[ 08:24 AM ] - WOPRAI
[ 08:23 AM ] - WOPRAI
[ 08:21 AM ] - WOPRAI
[ 08:18 AM ] - WOPRAI
[ 08:14 AM ] - WOPRAI
[ 08:10 AM ] - WOPRAI
[ 08:05 AM ] - WOPRAI
[ 08:02 AM ] - WOPRAI
[ 07:58 AM ] - WOPRAI
[ 07:49 AM ] - WOPRAI
[ 07:45 AM ] - WOPRAI
[ 07:00 AM ] - Market Wire
[ 06:00 AM ] - Market Wire
[ 05:00 AM ] - Market Wire
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Michael Wiederhorn Maintained (AMED) at Buy with Decreased Target to $14 on, Mar 13th, 2013
Michael Wiederhorn of Oppenheimer, Maintained "Amedisys, Inc." (AMED) at Buy with Decreased Target from $15 to $14 on, Mar 13th, 2013.
Michael has made no other calls on AMED in the last 4 months.
There is 1 other peer that has a rating on AMED. Out of the 1 peers that are also analyzing AMED, 0 agree with Michael's Rating of Hold.
This is the rating of the analyst that currently disagrees with Michael
- John Ransom of "Raymond James" Downgraded from Hold to Sell on, Thursday, February 21st, 2013